Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Citius Pharmaceuticals Inc fell by 15.23m. Cash Flow from Financing totalled 13.83m or -- of revenues. In addition the company used 29.06m for operations while cash from investing was breakeven.
Cash flow per share | -0.2353 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.4741 |
---|---|
Tangible book value per share | 0.0937 |
More ▼
Balance sheet in USDView more
Current ratio | 6.75 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼